Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) major shareholder J.H. Whitney Equity Partners V sold 750,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $5.20, for a total transaction of $3,900,000.00. Following the sale, the insider now owns 28,890,756 shares of the company’s stock, valued at $150,231,931.20. This represents a 2.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
J.H. Whitney Equity Partners V also recently made the following trade(s):
- On Monday, May 19th, J.H. Whitney Equity Partners V sold 1,560,700 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.36, for a total value of $8,365,352.00.
- On Monday, May 12th, J.H. Whitney Equity Partners V sold 47,039 shares of Aveanna Healthcare stock. The shares were sold at an average price of $5.72, for a total value of $269,063.08.
- On Tuesday, April 1st, J.H. Whitney Equity Partners V sold 5,580 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.63, for a total value of $31,415.40.
- On Monday, March 24th, J.H. Whitney Equity Partners V sold 268 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.63, for a total value of $1,508.84.
- On Tuesday, March 18th, J.H. Whitney Equity Partners V sold 61,564 shares of Aveanna Healthcare stock. The shares were sold at an average price of $5.51, for a total transaction of $339,217.64.
Aveanna Healthcare Price Performance
NASDAQ AVAH opened at $4.91 on Friday. The company has a market cap of $957.91 million, a P/E ratio of -14.44 and a beta of 2.03. The stock has a 50-day moving average of $5.09 and a two-hundred day moving average of $4.92. Aveanna Healthcare Holdings Inc. has a 1-year low of $2.32 and a 1-year high of $6.19.
Institutional Inflows and Outflows
Analyst Ratings Changes
AVAH has been the topic of a number of research analyst reports. UBS Group boosted their price target on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the company a “sell” rating in a research note on Friday, May 9th. Truist Financial cut their target price on Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating on the stock in a research report on Friday, April 11th.
Check Out Our Latest Stock Report on Aveanna Healthcare
Aveanna Healthcare Company Profile
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Recommended Stories
- Five stocks we like better than Aveanna Healthcare
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
- ESG Stocks, What Investors Should Know
- Upstart Stock’s Bull Case Just Got a Lot Stronger
- The Most Important Warren Buffett Stock for Investors: His Own
- Higher Gulf Oil Output Puts These Energy Names in Play
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.